News

News Archive

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned...
A. Menarini Diagnostics and Sinocare Announce Exclusive Distribution Agreement for New Continuous Glucose Monitoring System

A. Menarini Diagnostics and Sinocare Announce Exclusive Distribution Agreement for New Continuous Glucose Monitoring System

A. Menarini Diagnostics announces an exclusive Distribution Agreement with Sinocare to register, promote, distribute, and market a new Sinocare 3rd Generation Continuous Glucose...
On Radar, “In Super Abili”: inclusività e sport al centro del nuovo incontro

On Radar, “In Super Abili”: inclusività e sport al centro del nuovo incontro

Content available only in Italian language

Fair Play Menarini – The Champions Tell their Stories: tales of sport and life triumph at the talk show

Fair Play Menarini – The Champions Tell their Stories: tales of sport and life triumph at the talk show

Thoughts, anecdotes and unexpected backstories providing an insight into sport. It was an emotion-packed evening for the talk show Fair Play Menarini – The Champions Tell their...
Fair Play Menarini – The Champions Tell their Stories, the sporting stars are ready to light up Palazzo Vecchio

Fair Play Menarini – The Champions Tell their Stories, the sporting stars are ready to light up Palazzo Vecchio

The wait is almost over. Tomorrow, Saturday 30 November, marks the day of the long-awaited talk show Fair Play Menarini – The Champions Tell their Stories. The thoughts and...
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+,

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+,

The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned...
1345678910Last

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Go to Follow our blog

Follow our blog

Discover our stories from all over the world

Read More